Fujun Li

1.6k total citations
62 papers, 1.3k citations indexed

About

Fujun Li is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Fujun Li has authored 62 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Oncology and 12 papers in Surgery. Recurrent topics in Fujun Li's work include Multiple Myeloma Research and Treatments (9 papers), Cytokine Signaling Pathways and Interactions (8 papers) and MicroRNA in disease regulation (7 papers). Fujun Li is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Cytokine Signaling Pathways and Interactions (8 papers) and MicroRNA in disease regulation (7 papers). Fujun Li collaborates with scholars based in China, United States and Japan. Fujun Li's co-authors include Hideaki Ishikawa, Shangqin Liu, Naohiro Tsuyama, Michio Kawano, Tom Alfredson, Saeid Abroun, Hans Maag, Guangxin Jin, Dequan Wu and Ken‐ichiro Otsuyama and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Fujun Li

58 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fujun Li China	20	607	345	202	186	174	62	1.3k
Huan Deng China	23	692 1.1×	321 0.9×	240 1.2×	254 1.4×	180 1.0×	84	1.7k
Rosaria Arcone Italy	18	584 1.0×	322 0.9×	188 0.9×	442 2.4×	135 0.8×	45	1.6k
Kageaki Kuribayashi Japan	19	607 1.0×	262 0.8×	160 0.8×	184 1.0×	94 0.5×	54	1.2k
Geoffrey M. Matthews Australia	23	863 1.4×	254 0.7×	125 0.6×	338 1.8×	174 1.0×	42	1.8k
Arun Kumar Trivedi India	24	940 1.5×	327 0.9×	165 0.8×	162 0.9×	68 0.4×	70	1.5k
DA-TIAN BAU Taiwan	18	643 1.1×	305 0.9×	390 1.9×	131 0.7×	154 0.9×	144	1.4k
C Shih United States	14	646 1.1×	448 1.3×	137 0.7×	115 0.6×	206 1.2×	22	1.8k
Hui‐Chi Hsu Taiwan	16	496 0.8×	239 0.7×	155 0.8×	207 1.1×	73 0.4×	51	1.4k
Atieh Pourbagheri‐Sigaroodi Iran	22	638 1.1×	277 0.8×	214 1.1×	285 1.5×	74 0.4×	59	1.4k

Countries citing papers authored by Fujun Li

Since Specialization

Citations

This map shows the geographic impact of Fujun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fujun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fujun Li more than expected).

Fields of papers citing papers by Fujun Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fujun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fujun Li. The network helps show where Fujun Li may publish in the future.

Co-authorship network of co-authors of Fujun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Fujun Li. A scholar is included among the top collaborators of Fujun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fujun Li. Fujun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ali, Maratab, et al.. (2024). Physiological and transcriptomic analysis revealed the quality regulatory mechanism of pyridoxine (vitamin B6) in fresh-cut apple. Postharvest Biology and Technology. 217. 113098–113098. 5 indexed citations

Li, Fujun, et al.. (2023). A novel role of prognostic nutritional index in predicting the effectiveness of infliximab in Crohn's disease. Annals of Medicine. 55(1). 2236011–2236011. 4 indexed citations

Gu, Lei, et al.. (2023). Facilitating endoscopic full‐thickness resection for gastric submucosal tumors with a novel snare traction method (with video). Journal of Gastroenterology and Hepatology. 39(3). 535–543. 4 indexed citations

Smith, Patrick F., Long Li, Fujun Li, et al.. (2023). Rilzabrutinib, a reversible covalent Bruton's tyrosine kinase inhibitor: Absorption, metabolism, excretion, and absolute bioavailability in healthy participants. Clinical and Translational Science. 16(7). 1210–1219. 11 indexed citations

Chen, Yongcheng, Yanrong Yu, Fujun Li, et al.. (2023). Bioinformatics combined with clinical data to analyze clinical characteristics and prognosis in patients with HER2 low expression breast cancer. Gland Surgery. 12(2). 197–207. 1 indexed citations

Zhang, Ying, Ping Li, Jifeng Zhang, et al.. (2023). Case report: Levodopa-responsive parkinsonism with akinetic mutism after ventriculo-peritoneal shunt. Frontiers in Neurology. 14. 1184713–1184713.

Tang, Xiaoping, Yanyan Shi, Lan Chen, et al.. (2022). Clinical outcome of non-alcoholic fatty liver disease: an 11-year follow-up study. BMJ Open. 12(6). e054891–e054891. 7 indexed citations

Li, Fujun, et al.. (2022). Less is not necessarily more: low-dose corticosteroid therapy and long-term prognosis in generalized myasthenia gravis after thymectomy. Neurological Sciences. 43(6). 3949–3956. 1 indexed citations

Zhang, Yingtao, et al.. (2019). [Characteristic fingerprint and multi-components quantitative determination for Fuke Qianjin Capsules by HPLC].. PubMed. 44(8). 1564–1572. 2 indexed citations

10.

Shea, Lauren, Kazuhito Honjo, David T. Redden, et al.. (2019). Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status. Blood Cancer Journal. 9(6). 47–47. 9 indexed citations

11.

Zong, Xuemei, Shuguang Wu, Fujun Li, et al.. (2017). Transplantation of VEGF-mediated bone marrow mesenchymal stem cells promotes functional improvement in a rat acute cerebral infarction model. Brain Research. 1676. 9–18. 29 indexed citations

12.

Li, Fujun, et al.. (2016). miR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression. Oncology Reports. 35(5). 2859–2865. 27 indexed citations

13.

Yang, Jing, San-Jue Hu, Fujun Li, & Jun-Ling Xing. (2014). Resonance characteristic and its ionic basis of rat mesencephalic trigeminal neurons. Brain Research. 1596. 1–12. 4 indexed citations

14.

Yao, Lei, et al.. (2012). Smad4 Expression in Hepatocellular Carcinoma Differs by Hepatitis Status. Asian Pacific Journal of Cancer Prevention. 13(4). 1297–1303. 12 indexed citations

15.

Yin, Yani, Chunlian Wang, Xiaowei Liu, et al.. (2011). Gastric and Duodenum Microflora Analysis After Long-Term Helicobacter pylori Infection in Mongolian Gerbils. Helicobacter. 16(5). 389–397. 39 indexed citations

16.

Wang, Xueping, et al.. (2009). [Construction of pSG5/NS5A5BdeltaC and its expression in Huh7 cells].. PubMed. 25(1). 31–4.

17.

Chen, Wen-Ke, Yi-You Zou, Fujun Li, & Dan Luo. (2007). Changes of psychosocial factors, enteric mucosal mast cells and 5-hydroxytryptamine in irritable bowel syndrome. World Chinese Journal of Digestology. 15(1). 46–46. 4 indexed citations

18.

Li, Fujun, Hans Maag, & Tom Alfredson. (2007). Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting. Journal of Pharmaceutical Sciences. 97(3). 1109–1134. 120 indexed citations

19.

Ishikawa, Hideaki, Naohiro Tsuyama, Shangqin Liu, et al.. (2005). Accelerated proliferation of myeloma cells by interleukin-6 cooperating with fibroblast growth factor receptor 3-mediated signals. Oncogene. 24(41). 6328–6332. 28 indexed citations

20.

Han, Zhiqiang, Ali Zhang, Mingfu Wu, et al.. (2004). [Correlation of expression of RhoA (RhoC and their effector ROCK-1 with malignant phenotype of ovarian cancer cells in vitro].. PubMed. 26(7). 385–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact